Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Apr 15:6:167.
doi: 10.3389/fimmu.2015.00167. eCollection 2015.

Autoantibodies in systemic sclerosis: unanswered questions

Cristiane Kayser  1 , Marvin J Fritzler  2
Affiliations
Review

Autoantibodies in systemic sclerosis: unanswered questions

Cristiane Kayser et al. Front Immunol. .

Abstract

Systemic sclerosis (SSc) is an autoimmune disease characterized by vascular abnormalities, and cutaneous and visceral fibrosis. Serum autoantibodies directed to multiple intracellular antigens are present in more than 95% of patients and are considered a hallmark of SSc. They are helpful biomarkers for the early diagnosis of SSc and are associated with distinctive clinical manifestations. With the advent of more sensitive, multiplexed immunoassays, new and old questions about the relevance of autoantibodies in SSc are emerging. In this review, we discuss the clinical relevance of autoantibodies in SSc emphasizing the more recently published data. Moreover, we will summarize recent advances regarding the stability of SSc autoantibodies over the course of disease, whether they are mutually exclusive and their potential roles in the disease pathogenesis.

Keywords: anti-nuclear antibodies; autoantibodies; autoimmune diseases; scleroderma; systemic sclerosis.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol (1988) 15:202–5. - PubMed
    1. Mehra S, Walker J, Patterson K, Fritzler MJ. Autoantibodies in systemic sclerosis. Autoimmun Rev (2013) 12:340–5410.1016/j.autrev.2012.05.011 - DOI - PubMed
    1. Arnett FC. Is scleroderma an autoantibody mediated disease? Curr Opin Rheumatol (2006) 18:579–81.10.1097/01.bor.0000245726.33006.c3 - DOI - PubMed
    1. van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum (2013) 65:2737–4710.1002/art.38098 - DOI - PMC - PubMed
    1. Villalta D, Imbastaro T, Di Giovanni S, Lauriti C, Gabini M, Turi MC, et al. Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosis. Autoimmun Rev (2012) 12:114–20.10.1016/j.autrev.2012.07.005 - DOI - PubMed

LinkOut - more resources